IRCT20210720051946N1已完成3 期
Assessment of Intravenous Levocarnitine on the mortality and morbidity of patients with aluminum phosphide intoxication
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 65 years（—）
- 性别
- All
入选标准
- •aluminum phosphide intoxication
- •Positive silver nitrate test
- •Systolic blood pressure lower than 90 mmHg
- •Serum bicarbonate less than 15 mEq/L
- •Blood pH lower than 7.2
- •Cardiac output of 15 and above
排除标准
- •Patients or caregivers who do not provide written informed consent
研究者
相似试验
已完成
不适用
Investigation of efficacy of levocarnitine intravenous formulation in patients undergoing hemodialysisJPRN-UMIN000035143Ministry of Education, Culture, Sports, Science and Technology96
已完成
不适用
Prevalence rate of carnitine and zinc deficiency and the efficacy of levocarnitine injection therapy in dialysis patients with renal anemiaEnd-stage kidney disease undergoing hemodialysis or peritoneal dialysis with renal anemia.JPRN-UMIN000025327ihon University School of Medicine90
已完成
不适用
Effect of intravenous Carnitine on anemia in hemodialysis patientsCondition 1: Hemodialysis. Condition 2: Anaemia.Anaemia in chronic diseases classified elsewhereChronic renal failureIRCT201010044865N1Zanjan University of Medical Sciences29
已完成
不适用
Exploratory study of intravenous L-carnitine in fatigue-improvement on the patients bearing endstage cancerMalignancyJPRN-UMIN000027078Mitoyo General Hospital10
招募中
不适用
The Effect of Levocarnitine on the Patient with Non-alcoholic Fatty Liver DiseaseJPRN-UMIN000009133Kanazawa University Graduate School of Medical Science, Disease Contral and Homeostasis80